Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection.

O'Donnell MR, Padayatchi N, Kvasnovsky C, Werner L, Master I, Horsburgh CR Jr.

Emerg Infect Dis. 2013 Mar;19(3):416-24. doi: 10.3201/eid1903.120998.

2.

Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting.

Gandhi NR, Andrews JR, Brust JC, Montreuil R, Weissman D, Heo M, Moll AP, Friedland GH, Shah NS.

Int J Tuberc Lung Dis. 2012 Jan;16(1):90-7. doi: 10.5588/ijtld.11.0153.

3.

Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study.

Pietersen E, Ignatius E, Streicher EM, Mastrapa B, Padanilam X, Pooran A, Badri M, Lesosky M, van Helden P, Sirgel FA, Warren R, Dheda K.

Lancet. 2014 Apr 5;383(9924):1230-9. doi: 10.1016/S0140-6736(13)62675-6. Epub 2014 Jan 17.

PMID:
24439237
4.

Clofazimine in the treatment of extensively drug-resistant tuberculosis with HIV coinfection in South Africa: a retrospective cohort study.

Padayatchi N, Gopal M, Naidoo R, Werner L, Naidoo K, Master I, O'Donnell MR.

J Antimicrob Chemother. 2014 Nov;69(11):3103-7. doi: 10.1093/jac/dku235. Epub 2014 Jun 30.

5.

Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study.

Dheda K, Shean K, Zumla A, Badri M, Streicher EM, Page-Shipp L, Willcox P, John MA, Reubenson G, Govindasamy D, Wong M, Padanilam X, Dziwiecki A, van Helden PD, Siwendu S, Jarand J, Menezes CN, Burns A, Victor T, Warren R, Grobusch MP, van der Walt M, Kvasnovsky C.

Lancet. 2010 May 22;375(9728):1798-807. doi: 10.1016/S0140-6736(10)60492-8.

6.

Survival from XDR-TB is associated with modifiable clinical characteristics in rural South Africa.

Shenoi SV, Brooks RP, Barbour R, Altice FL, Zelterman D, Moll AP, Master I, van der Merwe TL, Friedland GH.

PLoS One. 2012;7(3):e31786. doi: 10.1371/journal.pone.0031786. Epub 2012 Mar 6.

7.

Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis.

Kim DH, Kim HJ, Park SK, Kong SJ, Kim YS, Kim TH, Kim EK, Lee KM, Lee SS, Park JS, Koh WJ, Lee CH, Shim TS.

Am J Respir Crit Care Med. 2010 Jul 1;182(1):113-9. doi: 10.1164/rccm.200911-1656OC. Epub 2010 Mar 11.

PMID:
20224066
8.

Extensively drug-resistant tuberculosis in children with human immunodeficiency virus in rural South Africa.

Thomas TA, Shenoi SV, Heysell SK, Eksteen FJ, Sunkari VB, Gandhi NR, Friedland G, Shah NS.

Int J Tuberc Lung Dis. 2010 Oct;14(10):1244-51.

9.

Partial extensively drug-resistant tuberculosis in an HIV-infected child: a case report and review of literature.

Uppuluri R, Shah I.

J Int Assoc Provid AIDS Care. 2014 Mar-Apr;13(2):117-9. doi: 10.1177/2325957413516384. Epub 2014 Jan 8. Review.

PMID:
24401768
10.

Malnutrition associated with unfavorable outcome and death among South African MDR-TB and HIV co-infected children.

Hicks RM, Padayatchi N, Shah NS, Wolf A, Werner L, Sunkari VB, O'Donnell MR.

Int J Tuberc Lung Dis. 2014 Sep;18(9):1074-83. doi: 10.5588/ijtld.14.0231.

PMID:
25189555
11.

Adherence in the treatment of patients with extensively drug-resistant tuberculosis and HIV in South Africa: a prospective cohort study.

OʼDonnell MR, Wolf A, Werner L, Horsburgh CR, Padayatchi N.

J Acquir Immune Defic Syndr. 2014 Sep 1;67(1):22-9. doi: 10.1097/QAI.0000000000000221.

12.

Impact of tuberculosis treatment on CD4 cell count, HIV RNA, and p24 antigen in patients with HIV and tuberculosis.

Wejse C, Furtado A, Camara C, Lüneborg-Nielsen M, Sodemann M, Gerstoft J, Katzenstein TL.

Int J Infect Dis. 2013 Oct;17(10):e907-12. doi: 10.1016/j.ijid.2013.05.003. Epub 2013 Jun 28.

13.

Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa.

Shean K, Streicher E, Pieterson E, Symons G, van Zyl Smit R, Theron G, Lehloenya R, Padanilam X, Wilcox P, Victor TC, van Helden P, Grobusch MP, Warren R, Badri M, Dheda K.

PLoS One. 2013 May 7;8(5):e63057. doi: 10.1371/journal.pone.0063057. Print 2013. Erratum in: PLoS One. 2013;8(5). doi:10.1371/annotation/644591a8-8ae6-450e-974e-1cd1f08f52c7. Groubusch, Martin [corrected to Grobusch, Martin P].

14.

Favorable outcomes for multidrug and extensively drug resistant tuberculosis patients undergoing surgery.

Vashakidze S, Gogishvili S, Nikolaishvili K, Dzidzikashvili N, Tukvadze N, Blumberg HM, Kempker RR.

Ann Thorac Surg. 2013 Jun;95(6):1892-8. doi: 10.1016/j.athoracsur.2013.03.067. Epub 2013 May 1.

15.

Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.

Hafkin J, Modongo C, Newcomb C, Lowenthal E, MacGregor RR, Steenhoff AP, Friedman H, Bisson GP.

Int J Tuberc Lung Dis. 2013 Mar;17(3):348-53. doi: 10.5588/ijtld.12.0100. Epub 2013 Jan 14.

16.

Programmatically selected multidrug-resistant strains drive the emergence of extensively drug-resistant tuberculosis in South Africa.

Müller B, Chihota VN, Pillay M, Klopper M, Streicher EM, Coetzee G, Trollip A, Hayes C, Bosman ME, Gey van Pittius NC, Victor TC, Gagneux S, van Helden PD, Warren RM.

PLoS One. 2013 Aug 23;8(8):e70919. doi: 10.1371/journal.pone.0070919. eCollection 2013.

17.

Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.

Park SK, Kim JH, Kang H, Cho JS, Smego RA Jr.

Int J Infect Dis. 2009 Mar;13(2):170-5. doi: 10.1016/j.ijid.2008.06.001. Epub 2008 Sep 2.

18.

HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality.

Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, Scott M, Weissman D, Marra C, Lalloo UG, Friedland GH; Tugela Ferry Care and Research (TF CARES) Collaboration.

Am J Respir Crit Care Med. 2010 Jan 1;181(1):80-6. doi: 10.1164/rccm.200907-0989OC. Epub 2009 Oct 15.

PMID:
19833824
19.

Beyond multidrug-resistant tuberculosis in Europe: a TBNET study.

Günther G, van Leth F, Altet N, Dedicoat M, Duarte R, Gualano G, Kunst H, Muylle I, Spinu V, Tiberi S, Viiklepp P, Lange C; TBNET.

Int J Tuberc Lung Dis. 2015 Dec;19(12):1524-7. doi: 10.5588/ijtld.15.0274.

PMID:
26614196
20.

Improved early results for patients with extensively drug-resistant tuberculosis and HIV in South Africa.

O'Donnell MR, Padayatchi N, Master I, Osburn G, Horsburgh CR.

Int J Tuberc Lung Dis. 2009 Jul;13(7):855-61.

Supplemental Content

Support Center